call 1800 257 600 email [email protected]

Pulmonary Epithelioid Haemangioendothelioma

Pulmonary epithelioid haemangioendothelioma (pulmonary EHE) is a very rare type of cancer that develops from epithelial cells in the lining of the lung. Haemangioendothelioma is a term used to describe neoplasms that act in-between a hemangioma (a benign growth composed of blood vessel cells) and an angiosarcoma (a malignancy found in the lining of blood vessels).

The respiratory system is composed of the nose, mouth, trachea and airways (bronchi and bronchioles) that lead to the lungs, which is where the breathing process primarily occurs. Each lung is made up of lobes, with the right lung being composed of three lobes and the left only having two lobes to accommodate room for the heart. The lungs sit on top of a muscle called the diaphragm, which separates the abdomen from the chest. The diaphragm works by contracting/flattening when we inhale, pulling air into the lungs. When we exhale, the diaphragm relaxes and pushes air out of the lungs. The space between the lungs is called the mediastinum, and holds several important structures, including the heart, trachea, oesophagus and lymph nodes. Each lung is covered by a layer of tissue called the pleura.

Pulmonary EHE is more commonly diagnosed in females, and tends to be diagnosed between the ages of 25-54. However, anyone can develop this disease.

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, because of how rare pulmonary EHEs are, there is currently no standard staging and grading system for this disease. Instead of staging and grading, your doctor will recommend a treatment plan based on the following factors:

  • Cancer location.
  • Whether or not the cancer has metastasised.
  • Your age.
  • General health.
  • Your treatment preferences.

Your doctor may also recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment options for pulmonary EHE may include:

  • Surgery to remove as much of the tumour as possible.
  • Chemotherapy.
  • Radiation therapy.
  • Clinical trials.
  • Palliative care.

Risk factors

Because of how rare pulmonary EHEs are, there has been limited research done into the risk factors of this disease.

Symptoms

Symptoms of pulmonary EHE may include:

  • Chest tightness.
  • Dyspnea.
  • Persistent cough.
  • Haemoptysis.
  • Fatigue.
  • Pleural effusion (fluid in the chest).

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

In some cases, pulmonary EHE can be found incidentally while investigating another condition. If your doctor suspects you have pulmonary EHE, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Blood tests.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging)
    • CT (computed tomography) scan.
    • Chest X-ray.
  • Pulmonary function test.
  • Sputum cytology.
  • Thoracentesis.
  • Exploratory surgery, potentially including:
    • Bronchoscopy.
    • Mediastinoscopy.
    • Thoracoscopy.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.